Clinical trial
Evaluate the Utility of Shear Wave Sonoelastography as a Tool to Measure Liver Fibrosis Grade
NCT01747772 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluate the Utility of Shear Wave Sonoelastography as a Tool to Measure Liver Fibrosis Grade
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- February 14, 2014
- Enrollment
- 180 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic liver disease, drug-induced liver injury, hepatitis b virus (hbv), hepatitis c virus (hcv) coinfection, non-alcoholic fatty liver disease